Spleen fibroblastic reticular cell-derived acetylcholine promotes lipid metabolism to drive autoreactive B cell responses

• DOI: 10.1016/j.cmet.2023.03.010
• Publication Date: 2023-04-05T22:44:20Z
• Authors: Qin Zeng; Shuyi Wang; Mengyuan Li; Shuang Wang; Chaohuan Guo; Xinyuan Ruan; Ryu Watanabe; Yimei Lai; Yuefang Huang; Xiaoyu Yin; Chuanzhao Zhang; Binfeng Chen; Niansheng Yang; Hui Zhang
• Keywords: Mice; Animals; Lupus Erythematosus, Systemic; Lipid Metabolism; Lipids; Spleen; Acetylcholine; 3. Good health

Autoreactive B cell responses are essential for the development of systemic lupus erythematosus (SLE). Fibroblastic reticular cells (FRCs) are known to construct lymphoid compartments and regulate immune functions. Here, we identify spleen FRC-derived acetylcholine (ACh) as a key factor that controls autoreactive B cell responses in SLE. In SLE, CD36-mediated lipid uptake leads to enhanced mitochondrial oxidative phosphorylation in B cells. Accordingly, the inhibition of fatty acid oxidation results in reduced autoreactive B cell responses and ameliorated diseases in lupus mice. Ablation of CD36 in B cells impairs lipid uptake and differentiation of autoreactive B cells during autoimmune induction. Mechanistically, spleen FRC-derived ACh promotes lipid influx and generation of autoreactive B cells through CD36. Together, our data uncover a novel function of spleen FRCs in lipid metabolism and B cell differentiation, placing spleen FRC-derived ACh in a key position in promoting autoreactive B cells in SLE.